Journal of Preventive Veterinary Medicine

  • 제42권4호
  • /
  • Pages.148-156
  • /
  • 2018
  • /
  • 2287-7991(pISSN)
  • /
  • 2287-8009(eISSN)
한국예방수의학회 (The Korean Society of Preventive Veterinary Medicine)
권호 표지
DOI QR코드

DOI QR Code

Antibiotic susceptibility of Clostridium perfringens type D isolated from feces of goats

  • Kim, Jun-Ho (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University) ;
  • Kim, Jeong-Hwa (Gyeongbuk Veterinary Service Laboratory) ;
  • Kim, Young-Hoan (Gyeongbuk Veterinary Service Laboratory) ;
  • Cho, Kwang-Hyun (Gyeongbuk Veterinary Service Laboratory) ;
  • Nam, Sang Yoon (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University) ;
  • Lee, Hu-Jang (College of Veterinary Medicine and Institute of Animal Medicine, Gyeongsang National University) ;
  • Lee, Beom Jun (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University)
  • 투고 : 2018.09.25
  • 심사 : 2018.11.07
  • 발행 : 2018.12.31
⟨ 이전 논문 다음 논문 ⟩

초록

Clostridium perfringens (C. perfringens) may cause diarrhea and enterotoxemia in adult and young livestock, leading to problems in the production and management of farms. Four hundred fecal samples were collected from 25 goat farms located in Gyeongsangbuk-do Province in the Republic of Korea. Sixteen C. perfringens strains were isolates from fecal samples, and the isolates were identified as type A (n=11) and type D (n=5). Additionally, ${\alpha}$- and ${\varepsilon}$-toxin genes were detected in 16 and 5 strains by PCR, respectively, and the enterotoxin gene was presented in 2 strains. The antibiotic susceptibility test was performed using the disk diffusion method and E-test method. In the disk diffusion method, ampicillin (n=16) and chloramphenicol (n=15) were highly susceptible to 16 C. perfringens isolates. In the E-test method, ampicillin, amoxicillin, amoxicillin/clavulanic acid and meropenem were susceptible to more than 14 of 16 C. perfringens isolates. This study indicates that administration of antibiotics such as ampicillin, amoxicillin/clavulanic acid and meropenem can prevent and treat C. perfringens infections in goats.

키워드

과제정보

연구 과제 주관 기관 : Gyeongbuk Veterinary Service Laboratory

참고문헌

  1. Akhi MT, Bidar Asl S, Pirzadeh T, Naghili B, Yeganeh F, Memar Y, Mohammadzadeh Y. Antibiotic sensitivity of Clostridium perfringens isolated from faeces in Tabriz, Iran. Jundishapur J Microbiol. 2015, 8: e20863.
  2. Andrews JM, Howe RA. BSAC standardized disk susceptibility testing method (version 10). J Antimicrob Chemother. 2011, 66: 2726-2757. https://doi.org/10.1093/jac/dkr359
  3. Chen J, Ma M, Uzal FA, McClane BA. Host cell-induced signaling causes Clostridium perfringens to upregulate production of toxins important for intestinal infections. Gut Microbes. 2013, 5: 96-107.
  4. Coursodon CF, Glock RD, Moore KL, Cooper KK, Songer JG. TpeL-producing strains of Clostridium perfringens type A are highly virulent for broiler chicks. Anaerobe. 2012, 18: 117-121. https://doi.org/10.1016/j.anaerobe.2011.10.001
  5. Hassan KA, Elbourne LD, Tetu SG, Melville SB, Rood JI, Paulsen IT. Genomic analyses of Clostridium perfringens isolates from five toxinotypes. Res Microbiol. 2015, 166: 255-263. https://doi.org/10.1016/j.resmic.2014.10.003
  6. Johnson MJ, Thatcher E, Cox ME. Antimicrobial susceptibility tests for anaerobic bacteria with use of the disk diffusion method. Clin Infect Dis. 2017, 20: 334-336.
  7. Kalender H, Ertas HB, Cetnkaya B, Muz A, Arslan N, Kilic A. Typing of isolates of Clostridium perfringens from healthy and diseased sheep by multiplex PCR. Vet. Med.-Czech. 2005, 50: 439-442.
  8. Kiu R, Hall LJ. An update on the human and animal enteric pathogen Clostridium perfringens. Emerg Microbes Infect. 2018, 7: 141.
  9. Klaasen HL, Molkenboer MJ, Bakker J, Miserez R, Hani H, Frey J, Popoff MR, van den Bosch JF. Detection of the beta2 toxin gene of Clostridium perfringens in diarrhoeic piglets in the Netherlands and Switzerland. FEMS Immunol Med Microbiol. 1999, 24: 325-332.
  10. Kuroda S, Okada Y, Mita M, Okamoto Y, Kato H, Ueyama S, Fujii I, Morita S, Yoshida Y. Fulminant massive gas gangrene caused by Clostridium perfringens. Intern Med. 2005, 44: 499-502. https://doi.org/10.2169/internalmedicine.44.499
  11. Li J, Adams V, Bannam TL, Miyamoto K, Garcia JP, Uzal FA, Rood JI, McClane BA. Toxin plasmids of Clostridium perfringens. Microbiol Mol Biol Rev. 2013, 77: 208-233. https://doi.org/10.1128/MMBR.00062-12
  12. Luber P, Barteit E, Genschow E, Wagner J, Hahn H. Comparison of broth microdilution, E test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli. J Clin Microbiol. 2003, 41: 1062-1068. https://doi.org/10.1128/JCM.41.3.1062-1068.2003
  13. Mahony DE, Clark GA, Stringer MF, MacDonald MC, Duchesne DR, MAder JA. Rapid extraction of plasmids from Clostridium perfringens. Appl Environ Microbiol. 1986, 51: 521-523.
  14. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother. 1999, 43: 727-737. https://doi.org/10.1128/AAC.43.4.727
  15. Murdoch DA. Gram-Positive anaerobic Cocci. Clin Microbiol Rev. 1998, 11: 81-120. https://doi.org/10.1128/CMR.11.1.81
  16. Nachnani S, Scuteri A, Newman MG, Avanessian AB, Lomeli SL. E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms. J Periodontol. 1992, 63: 576-583. https://doi.org/10.1902/jop.1992.63.7.576
  17. Nagahama M, Ochi S, Oda M, Miyamoto K, Takehara M, Kobayashi K. Recent insights into Clostridium perfringens beta-toxin. Toxins. 2015, 7: 396-406. https://doi.org/10.3390/toxins7020396
  18. Nakano V, Ignacio A, Lianco L, Bueris V, Sircili MP, Avila-Campos MJ. Multilocus sequence typing analyses of Clostridium perfringens type A strains harboring tpeL and netB genes. Anaerobe. 2017, 44: 99-105. https://doi.org/10.1016/j.anaerobe.2017.02.017
  19. Nazki S, Wani SA, Parveen R, Ahangar SA, Kashoo ZA, Hamid S, Dar ZA, Dar TA, Dar PA. Isolation, molecular characterization and prevalence of Clostridium perfringens in sheep and goats of Kashmir Himalayas, India. Vet World. 2017, 10: 1501-1507. https://doi.org/10.14202/vetworld.2017.1501-1507
  20. Oliveira Junior CA, Silva ROS, Diniz AN, Pires PS, Salvarani FM, Assis RA, Lobato FCF. Antimicrobial susceptibility of Clostridium perfringens isolated from domestic and wild animal species in Brazil. Semin-Cienc Agrar. 2016, 37: 257-262. https://doi.org/10.5433/1679-0359.2016v37n1p257
  21. Park JY, Kim S, Oh JY, Kim HR, Jang I, Lee HS, Kwon YK. Characterization of Clostridium perfringens isolates obtained from 2010 to 2012 from chickens with necrotic enteritis in Korea. Poult Sci. 2015, 94: 1158-1164. https://doi.org/10.3382/ps/pev037
  22. Roberts SA, Shore KP, Paviour SD, Holland D, Morris AJ. Antimicrobial susceptibility of anaerobic bacteria in New Zealand. J Antimicrob Chemother. 2006, 57: 992-998. https://doi.org/10.1093/jac/dkl052
  23. Romaniuk JAH, Cegelski L. Bacterial cell wall composition and the influence of antibiotics by cell-wall and whole-cell NMR. Phil Trans R Soc B. 2015, 370: 20150024. https://doi.org/10.1098/rstb.2015.0024
  24. Singh DD, Pawaiya RS, Gururaj K, Gangwar NK, Mishra AK, Andani D, Singh MK, Bhushan S, Kumar A. Molecular detection of Clostridium perfringens toxinotypes, Enteropathogenic Escherichia coli, rotavirus and coronavirus in diarrheic fecal samples of neonatal goat kids. Vet Arhiv. 2018, 88: 1-20. https://doi.org/10.24099/vet.arhiv.161027
  25. Uzal FA. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. Anaerobe. 2004, 10: 135-143. https://doi.org/10.1016/j.anaerobe.2003.08.005
  26. Uzal FA, Plumb JJ, Blackall LL, Kelly WR. PCR detection of Clostridium perfringens producing different toxins in faeces of goats. Lett Appl Microbiol. 1997, 25: 339-344. https://doi.org/10.1046/j.1472-765X.1997.00247.x
  27. Uzal FA, Songer JG. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J Vet Diagn Invest. 2008, 20: 253-265. https://doi.org/10.1177/104063870802000301
  28. Uzal FA, Vidal JE, McClane BA, Gurjar AA. Clostridium Perfringens toxins involved in mammalian veterinary diseases. Open Toxinology J. 2014, 2: 24-42.
  29. van Asten AJ, van der Wiel CW, Nikolaou G, Houwers DJ, Grone A. A multiplex PCR for toxin typing of Clostridium perfringens isolates. Vet Microbiol. 2008, 136: 411-412.
  30. Yadav JP, Das SC, Dhaka P, Vijay D, Kumar M, Mukhopadhyay AK, Chowdhury G, Chauhan P, Singh R, Dhama K, Malik SVS, Kumar A. Molecular characterization and antimicrobial resistance profile of Clostridium perfringens type A isolates from humans, animals, fish and their environment. Anaerobe. 2017, 47: 120-124. https://doi.org/10.1016/j.anaerobe.2017.05.009
  31. Yoo HS, Lee SU, Park KY, Park YH. Molecular typing and epidemiological survey of prevalence of Clostridium perfringens types by multiplex PCR. J Clin Microbiol. 1997, 35: 228-232.